Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
TNGX similar filings
- 11 May 22 Tango Therapeutics Reports First Quarter 2022 Financial Results
- 28 Mar 22 Tango Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
- 9 Nov 21 Tango Therapeutics Reports Third Quarter 2021 Financial Results
- 13 Aug 21 Financial Condition and Results of Operations of Tango
- 14 Apr 21 Entry into a Material Definitive Agreement
- 7 Oct 20 Departure of Directors or Certain Officers
- 14 Sep 20 Report of Independent Registered Public Accounting Firm
Filing view
External links
Exhibit 16.1
August 13, 2021
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Ladies and Gentlemen:
We have read the statements of Tango Therapeutics, Inc. (formerly known as BCTG Acquisition Corp.) under Item 4.01(a) of its Form 8-K dated August 13, 2021. We agree with the statements concerning our Firm under Item 4.01(a), in which we were informed of our dismissal on August 10, 2021. We are not in a position to agree or disagree with other statements contained therein.
Very truly yours,
/s/ WithumSmith+Brown, PC
New York, New York